Literature DB >> 16915340

Clinico-pathological findings in cattle exposed to chronic bracken fern toxicity.

M D Perez-Alenza1, J Blanco, D Sardon, M A Sanchez Moreiro, A Rodriguez-Bertos.   

Abstract

AIM: To describe changes in blood and urine analytes in a large group of cattle exposed to chronic bracken fern toxicity, in order to identify parameters of potential diagnostic value.
METHODS: The study was conducted on two livestock farms on which bovine enzootic haematuria (BEH) was known to occur; Farm A grazed a local breed of cows and Farm B grazed Friesians. Group A1 comprised 66 cows from Farm A, Group B 54 cows from Farm B, and Group A2 13 heifers from Farm A. Ten healthy cows were used as controls. A complete physical examination was performed (Group A1), and blood (all groups) and urine (Groups A1 and B) samples were collected. Necropsies and histopathology were undertaken on four cows.
RESULTS: Anaemia, leucopenia, monocytosis, thrombocytopenia, hypergammaglobulinaemia, microhaematuria and proteinuria were detected. Multivariate statistical analyses established three phases of the disease of increasing severity; an initial phase, characterised by an extremely high monocytosis and otherwise normal parameters; an intermediate phase, characterised by monocytosis and moderate changes to other analytes; and a final phase, characterised by normal levels of monocytes and many changes to other analytes. CONCLUSIONS AND CLINICAL RELEVANCE: Monocytosis, detected in 31% of the younger animals, could represent an initial response to consumption of bracken fern and might be useful as an early haematological marker of BEH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915340     DOI: 10.1080/00480169.2006.36693

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  1 in total

1.  Fate of ptaquiloside-A bracken fern toxin-In cattle.

Authors:  Paulo César Dos Reis Aranha; Lars Holm Rasmussen; Godelind Alma Wolf-Jäckel; Henrik Michael Elvang Jensen; Hans Christian Bruun Hansen; Christian Friis
Journal:  PLoS One       Date:  2019-06-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.